JCR Pharmaceuticals Co (TSE:4552) Common Stock: 円9,061 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:4552 JCR Pharmaceuticals Co Ltd TSE:4552
42 GF Score
Price 円522.00
GF Value 円770.84
Valuation Possible Value Trap
! 7 Warning Signs
View Full Analysis

What is JCR Pharmaceuticals Co Common Stock?

JCR Pharmaceuticals Co TSE:4552 -0.38% 42 Common Stock is 円9,061 Mil as of Mar. 2026. GuruFocus rates TSE:4552 with a GF Score™ of 42/100 and a GF Value™ of 円770.84 (Possible Value Trap). The stock has 7 warning signs investors should review.

JCR Pharmaceuticals Co's quarterly common stock stayed the same from Sep. 2025 (円9,061 Mil) to Dec. 2025 (円9,061 Mil) and stayed the same from Dec. 2025 (円9,061 Mil) to Mar. 2026 (円9,061 Mil).

JCR Pharmaceuticals Co's annual common stock stayed the same from Mar. 2024 (円9,061 Mil) to Mar. 2025 (円9,061 Mil) and stayed the same from Mar. 2025 (円9,061 Mil) to Mar. 2026 (円9,061 Mil).

JCR Pharmaceuticals Co Common Stock Historical Data

* Premium members only.

The historical data trend for JCR Pharmaceuticals Co's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

JCR Pharmaceuticals Co Common Stock Chart

JCR Pharmaceuticals Co Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Common Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only 9,061.00 9,061.00 9,061.00 9,061.00 9,061.00

JCR Pharmaceuticals Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9,061.00 9,061.00 9,061.00 9,061.00 9,061.00
TSE:4552
42GF Score
JCR Pharmaceuticals Co Ltd TSE:4552
Common Stock is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

JCR Pharmaceuticals Co Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of 円9,061 Mil mean?
JCR Pharmaceuticals Co (TSE:4552) has a Common Stock of 円9,061 Mil as of Mar. 2026. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on JCR Pharmaceuticals Co and its competitors.
Is JCR Pharmaceuticals Co's Common Stock too high?
JCR Pharmaceuticals Co's current Common Stock is 円9,061 Mil. Overall, JCR Pharmaceuticals Co has a GF Score™ of 42/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does JCR Pharmaceuticals Co's Common Stock compare to LLY and JNJ?
JCR Pharmaceuticals Co's Common Stock of 円9,061 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Drug Manufacturers company?
A good Common Stock depends on the Drug Manufacturers industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on JCR Pharmaceuticals Co and its competitors. JCR Pharmaceuticals Co's current Common Stock is 円9,061 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is JCR Pharmaceuticals Co stock overvalued right now?
Based on GuruFocus' analysis, JCR Pharmaceuticals Co (TSE:4552) is currently considered Possible Value Trap. The stock's GF Value™ is 円770.84, compared to a current price of 円522.00 — trading 32.3% below its estimated fair value. The current Common Stock is 円9,061 Mil. JCR Pharmaceuticals Co's overall GF Score™ is 42/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For JCR Pharmaceuticals Co (TSE:4552), the current Common Stock is 円9,061 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is JCR Pharmaceuticals Co (TSE:4552) Overvalued in 2026?

Based on GuruFocus' analysis, JCR Pharmaceuticals Co stock appears to be undervalued. The current stock price of 円522.00 is trading 32.3% below its estimated GF Value™ of 円770.84. GuruFocus considers JCR Pharmaceuticals Co to be Possible Value Trap.

Key valuation signals for TSE:4552:

  • Common Stock: 円9,061 Mil
  • GF Value™: 円770.84 vs. price of 円522.00 (32.3% below fair value)
  • GF Score™: 42/100 with 7 warning signs

No single metric tells the full story. See the TSE:4552 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

JCR Pharmaceuticals Co Business Description

Other Exchanges JCRRF:USA
Address 3-19 Kasuga-cho, Ashiya, Hyogo, JPN, 659-0021
JCR Pharmaceuticals Co Ltd is a major drug manufacturing company proactively engaged in the research of enzymes and proteins. The company maintains a focus toward developing value-added treatment options to address unmet medical needs. JCR utilizes international partnerships as a component of its growth strategy. The vast majority of JCR's revenue is generated from its pharmaceutical operations, followed by medical devices and laboratory equipment. A portion of the company's sales are derived from licensing agreements.
42GF Score

Get the complete analysis for TSE:4552

Common Stock is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円522.00
Price
円770.84
GF Value